Authors: IRVIN WP PRICE FV BAILEY H GELDER M ROSENBLUTH R DURIVAGE HJ POTKUL RK

Citation: Wp. Irvin et al., A PHASE-II STUDY OF IRINOTECAN (CPT-11) IN PATIENTS WITH ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX, Cancer, 82(2), 1998, pp. 328-333

Authors: SCHULTZ MZ SANDLER AB DURIVAGE HJ COOPER DL

Citation: Mz. Schultz et al., A PHASE-I PILOT-STUDY OF BCNU PLUS THYMIDINE IN PATIENTS WITH REFRACTORY CANCER, Cancer investigation, 14(3), 1996, pp. 218-224

Authors: MURREN JR DURIVAGE HJ BUZAID AC REISS M FLYNN SD CARTER D HAIT WN

Citation: Jr. Murren et al., TRIFLUOPERAZINE AS A MODULATOR OF MULTIDRUG-RESISTANCE IN REFRACTORY BREAST-CANCER, Cancer chemotherapy and pharmacology, 38(1), 1996, pp. 65-70

Authors: MURREN JR DURIVAGE HJ ROSENBERG AH CHEN YT DELPRETE SA MURPHY GJ BUZAID AC HAIT WN

Citation: Jr. Murren et al., CISPLATIN, DOXORUBICIN, MITOMYCIN-C, AND 5-FLUOROURACIL FOR THE TREATMENT OF METASTATIC NONSMALL CELL LUNG-CANCER - LIMITED ACTIVITY OF AN AGGRESSIVE CHEMOTHERAPY REGIMEN, American journal of clinical oncology, 17(3), 1994, pp. 239-241

Authors: MARSH JC DURIVAGE HJ DAVIS C OHOLLAREN K PASQUALE DN SIMONICH SA VOYNICK IM BERTINO JR

Citation: Jc. Marsh et al., PHASE-II STUDY OF PULSE 5-FLUORO-2'-DEOXYURIDINE AND LEUCOVORIN IN ADVANCED COLORECTAL-CANCER PATIENTS PREVIOUSLY TREATED WITH CHEMOTHERAPY, American journal of clinical oncology, 15(2), 1992, pp. 115-118